This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

June 22-24, 2020
Hilton San Francisco Union Square,
San Francisco, CA

CAR and T Cell Therapies: Pioneering point of care with innovative manufacturing and commercialization strategies

Revolutionizing cell engineering - ground breaking autologous and allogeneic treatments for blood borne and solid tumors

ALERT!

Register by February 21st to save $900

Next Generation Technologies and Success Strategies….

Solid Tumours, Reducing Toxicity, Tackling Persistence & Enhancing Efficacy
  • Get to grips with solid tumour microenvironments and improving CAR function & potency
  • Exchange ideas on alternatives to CAR-T: CAR-NK, Gamma Delta T and TCR Therapies
  • Work towards better safety and efficacy with cytokine modulation and more…
Novel Gene Editing Applications in CART – PLUS NEW dedicated Gene Editing Track!
  • Understand next generations technologies in adoptive T cell immunotherapy
  • Prepare for allo CAR & T Cell Therapies – iPSc, Gene editing & highly characterized products
  • Build controls for product quality & specifications around gene editing
Automation & Process Development Strategies for Auto and Allo Cell Therapies
  • Prepare for commercialization with evolution in automation approaches
  • Streamline manufacturing to reduce CoGs and reduce turnaround time
  • Simplify manufacturing concepts for ‘off-the-shelf’ cell therapies

Which one would you consider yourself to be....?

I am a Pioneer

- An innovator who has been in the industry since conception and wants to put theory into practice

Why should I attend?

- Learn about the progression and commercialization of cell and gene therapies

- Hear from small emerging biotech's such as Baylor College of Medicine, Eureka Therapeautics, Triumriva Immunologics, Inc who are pitching big ideas

- Benchmark, network & meet peers and tech providers through the one-to-one meeting tool

I am STILL LEARNING

- Fairly new to the cell and gene therapy community with previous experience with MAb's and other modalities

Why should I attend?

- Hear how the industry think to apply my experience in the space

- Understand the industry landscape and where the gaps lie

- Have the opportunity for exposure, collaboration and success

I am a PROBLEM SOLVER

- I bring thought leadership to the table I have a clear definition of what the industry issues are

Why should I attend?

- Get access to all the key stakeholders in industry

- Gain authority in the field through building my personal brand

- Get an unrivaled opportunity to present cutting edge scientific data

Next Generation CAR & T Cell Therapies: 2019 Number Crunching

100+
attendees hit San Francisco in 2019 – Let’s make this year bigger and better
70+
companies represented in 2019 – Were you one of them?
3 DAYS
of in-depth programmes in key areas

CONNECT WITH KEY BUYERS AT NEXT GENERATION CAR & T CELL THERAPIES 2020 IN SAN FRANCISCO


Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

Contact Kristen Schott: KSchott@informaconnectls.com | +1 857 504 6685